Consulting Reference Information 8-3
P/N 85213-30, Manual revision: B
Table 8-1, AC solution concentration in MCS+ final collection products
AC Ratio 1:8 1:9 1:10 1:11 1:12 1:16
Donor
Hematocrit
% Anticoagulant in the plasma or platelet product
20 15.2 13.5 12.2 11.1 10.2 7.7
22 15.5 13.8 12.5 11.4 10.4 7.9
24 15.8 14.1 12.8 11.6 10.7 8.1
26 16.2 14.5 13.1 11.9 10.9 8.3
28 16.6 14.8 13.4 12.2 11.2 8.5
30 16.9 15.2 13.7 12.5 11.5 8.7
32 17.4 15.5 14.0 12.8 11.8 8.9
34 17.8 15.9 14.4 13.2 12.1 9.2
36 18.2 16.3 14.8 13.5 12.4 9.4
37 18.5 16.6 15.0 13.7 12.6 9.6
38 18.7 16.8 15.2 13.9 12.8 9.7
39 19.0 17.0 15.4 14.1 13.0 9.9
40 19.2 17.2 15.6 14.3 13.2 10.0
41 19.5 17.5 15.8 14.5 13.4 10.2
42 19.8 17.7 16.1 14.7 13.6 10.3
43 20.0 18.0 16.3 14.9 13.8 10.5
44 20.3 18.2 16.6 15.2 14.0 10.6
45 20.6 18.5 16.8 15.4 14.2 10.8
46 20.9 18.8 17.1 15.6 14.4 11.0
47 21.2 19.1 17.3 15.9 14.6 11.2
48 21.6 19.4 17.6 16.1 14.9 11.4
49 21.9 19.7 17.9 16.4 15.1 11.6
50 22.2 20.0 18.2 16.7 15.4 11.8
60 26.3 23.8 21.7 20.0 18.5 14.3
To Next Page
Loading...
